Minerva Surgical, Inc. provided earnings guidance for the fiscal year 2023. For the period, the company expects Revenue guidance remains consistent with the guidance given during the previous quarter, with annual revenue anticipated to be in the range of $52 to $55 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.001 USD | -99.76% | -99.78% | -99.91% |
Jan. 03 | Minerva Surgical, Inc.(OTCPK:UTRS) dropped from S&P TMI Index | CI |
2023 | Minerva Surgical, Inc.(OTCPK:UTRS) dropped from NASDAQ Composite Index | CI |
1st Jan change | Capi. | |
---|---|---|
-99.91% | 8.88K | |
+12.07% | 128B | |
-9.04% | 10.65B | |
+0.91% | 8.82B | |
+16.72% | 7.19B | |
+25.15% | 4.99B | |
+7.17% | 3.4B | |
-1.36% | 3.03B | |
-8.73% | 2.14B | |
-10.15% | 2B |
- Stock Market
- Equities
- UTRS Stock
- News Minerva Surgical, Inc.
- Minerva Surgical, Inc. Provides Earnings Guidance for the Fiscal Year 2023